Dutch Remedies Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 03-12-2024
- Paid Up Capital ₹ 0.83 M
as on 03-12-2024
- Company Age 20 Year, 7 Months
- Last Filing with ROC 31 Mar 2014
- Open Charges ₹ 4.00 Cr
as on 03-12-2024
- Satisfied Charges ₹ 3.03 Cr
as on 03-12-2024
About Dutch Remedies
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2014. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 0.83 M.
The company currently has active open charges totaling ₹4.00 Cr. The company has closed loans amounting to ₹3.03 Cr, as per Ministry of Corporate Affairs (MCA) records.
Aditya Banerjee, Rajuddin Mulani, and Mrutunjay Banerjee serve as directors at the Company.
- CIN/LLPIN
U51397MH2004PTC146333
- Company No.
146333
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 May 2004
- Date of AGM
30 Sep 2014
- Date of Balance Sheet
31 Mar 2014
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dutch Remedies?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Aditya Banerjee  | Director | 17-May-2004 | Current |
| Rajuddin Mulani | Director | 10-Apr-2012 | Current |
| Mrutunjay Banerjee | Additional Director | 06-Jan-2016 | Current |
Financial Performance of Dutch Remedies.
Enhance accessibility to Dutch Remedies's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dutch Remedies?
Unlock access to Dutch Remedies's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Dutch Remedies Edible Oil Private LimitedActive 12 years 4 monthsRajuddin Mulani and Mrutunjay Banerjee are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Deccan Merchants Co-Operative Bank Ltd. Creation Date: 03 Dec 2013 | ₹4.00 Cr | Open |
Abhinav Sahakari Bank Ltd. Creation Date: 13 Apr 2010 | ₹4.50 M | Satisfied |
The Abhinav Sahakari Bank Ltd. Creation Date: 27 Mar 2010 | ₹7.50 M | Satisfied |
How Many Employees Work at Dutch Remedies?
Unlock and access historical data on people associated with Dutch Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dutch Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dutch Remedies's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
